ALEXANDRIA, Va., July 16 -- United States Patent no. 12,359,183, issued on July 15, was assigned to Hansa Biopharma AB (Lund, Sweden).
"Cysteine protease" was invented by Christian Kjellman (Lund, Sweden), Sofia Jarnum (Lund, Sweden) and Emma Andersson Nordahl (Lund, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel polypeptide which displays IgG cysteine protease activity, and in vivo and ex vivo uses thereof. Uses of the polypeptide include methods for the prevention or treatment of diseases and conditions mediated by IgG, and methods for the analysis of IgG."
The patent was filed on May 16, 2023, under Application No. 18/318,455.
*For further information, inc...